XML 14 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Balance Sheets - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current Assets    
Cash and cash equivalents $ 7,976,106 $ 14,849,057
Inventories 3,513,860 109,798
Deferred clinical supply costs 846,301 4,256,793
License fee and expense reimbursements receivable 88,045 123,833
Security deposits, current 1,506 1,506
Prepaid expenses and other current assets 2,025,267 1,365,731
Total Current Assets 14,451,085 20,706,718
Property and equipment, net 3,155,710 3,374,384
Security deposits, non-current 197,168 197,168
Intangible assets 6,122,945 2,122,945
Operating lease right-of-use asset 1,538,814 1,666,718
Equipment deposits 711,441 711,441
Total Assets 26,177,163 28,779,374
Current Liabilities:    
Accounts payable 2,145,272 1,753,172
Accrued compensation 828,286 1,658,613
Accrued expenses and other current liabilities 4,751,755 287,928
Operating lease liabilities - current portion 579,585 501,250
Notes payable - current portion, net of debt discount of $621,712 and $503,914 as of March 31, 2024 and December 31, 2023, respectively 8,155,025 5,329,419
Total Current Liabilities 16,459,923 9,530,382
Operating lease liabilities - non-current portion 1,140,231 1,292,667
Notes payable - non-current portion, net of debt discount of $200,711 and $448,367 as of March 31, 2024 and December 31, 2023, respectively 2,103,456 4,355,800
Convertible notes payable - net of debt discount of $344,219 and $398,569 as of March 31, 2024 and December 31, 2023, respectively 4,655,781 4,601,431
Total Liabilities 24,359,391 19,780,280
Commitments and contingencies (Note 8)
Stockholders' Equity:    
Preferred stock, $0.0001 par value, 6,000,000 shares authorized; 0 shares issued and outstanding as of March 31, 2024 and December 31, 2023
Common stock, $0.0001 par value, 90,000,000 shares authorized; 47,386,349 and 45,553,026 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively 4,738 4,555
Additional paid-in capital 158,226,694 154,486,098
Accumulated deficit (156,413,660) (145,491,559)
Total Stockholders' Equity 1,817,772 8,999,094
Total Liabilities and Stockholders' Equity $ 26,177,163 $ 28,779,374